Vaccine Delivery Devices Market Size, Share, and Growth Analysis, By Type of Device, By Route of Administration, By End Users, By Region - Industry Forecast 2025-2032
백신 전달 기기 시장 규모는 2023년 67억 7,000만 달러로 평가되었습니다. 2024년 73억 3,000만 달러에서 2032년에는 138억 8,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.3%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 백신 전달 기기 시장은 예방접종 이니셔티브 증가와 효율적인 투여 방법에 대한 수요에 힘입어 강력한 성장세를 보이고 있습니다. 주요 촉진요인으로는 예방접종 프로그램의 확대, 주사바늘 기술의 발전, 예방 의료에 대한 인식 증가 등이 있습니다. 특히 적절한 냉장 시설이 없는 지역에서는 신뢰할 수 있는 콜드체인의 중요성이 강조되고 있습니다. 자동 비활성화 주사기 및 사전 충전된 주사기 시스템 등 최근 전달 장비의 기술 혁신은 안전성과 유효성을 향상시키고 있습니다. 현재 북미와 유럽이 시장을 주도하고 있지만, 아시아태평양은 큰 성장 잠재력을 가지고 있습니다. 백신 수요가 급증함에 따라 시장은 혁신적이고 사용하기 편리하며 비용 효율적인 전달 솔루션에 중점을 두고 진화할 준비가 되어 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 사례 연구
- 규제 상황
- 특허 분석
- 기술 분석
백신 전달 기기 시장 규모 : 디바이스 유형별&CAGR(2025-2032년)
- 시장 개요
- 무바늘 주사 시스템
- 경구 투여 시스템
- 비강 딜리버리 시스템
- 제트 인젝터
- 마이크로니들 패치
- 마이크로 인젝터
백신 전달 기기 시장 규모 : 투여 경로별&CAGR(2025-2032년)
- 시장 개요
- 피내 백신 접종
- 근육 백신 접종
- 피하 백신 접종
- 기타 예방 접종
백신 전달 기기 시장 규모 : 최종사용자별&CAGR(2025-2032년)
백신 전달 기기 시장 규모 : 지역별&CAGR(2025-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- Becton Dickinson & Company(USA)
- Bioject Medical Technologies, Inc.(USA)
- Inovio Pharmaceuticals, Inc.(USA)
- PharmaJet(USA)
- Vaxxas(Australia)
- Gerresheimer AG(Germany)
- SCHOTT AG(Germany)
- Corium International, Inc.(USA)
- 3 M(USA)
- West Pharmaceutical Services, Inc.(USA)
- Terumo Corporation(Japan)
- B. Braun Melsungen AG(Germany)
- Smiths Medical(UK)
- Medtronic(Ireland)
- Sanofi Pasteur(France)
- Novartis AG(Switzerland)
- Pfizer Inc.(USA)
- GlaxoSmithKline plc(UK)
- Merck & Co., Inc.(USA)
- Johnson & Johnson(USA)
결론과 제안
LSH
Vaccine Delivery Devices Market size was valued at USD 6.77 billion in 2023 and is poised to grow from USD 7.33 billion in 2024 to USD 13.88 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).
The global vaccine delivery devices market is experiencing robust growth, fueled by increased vaccination initiatives and the demand for efficient administration methods. Key drivers include the expansion of immunization programs, advancements in needle technology, and heightened awareness of preventive healthcare. A crucial concern remains the integrity of vaccines during storage and transport, emphasizing the importance of a reliable cold chain, particularly in areas lacking proper refrigeration. Recent innovations in delivery devices, including auto-disable syringes and prefilled syringe systems, enhance safety and efficacy. While North America and Europe currently lead the market, the Asia-Pacific region shows significant growth potential. As vaccine demand surges, the market is poised for evolution with an emphasis on innovative, user-friendly, and cost-effective delivery solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Vaccine Delivery Devices Market Segments Analysis
Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Vaccine Delivery Devices Market
The increasing demand for vaccines, fueled by continuous initiatives aimed at tackling infectious diseases like COVID-19 and various preventable illnesses, has created a significant driver for the vaccine delivery devices market. As global health efforts intensify, the necessity for efficient and reliable delivery systems becomes paramount to guarantee proper immunization. This surge in vaccine production and distribution emphasizes the critical role that advanced delivery devices play in enhancing vaccination rates and ensuring the effectiveness of immunization programs. Consequently, the growth of the vaccine delivery devices market is closely linked to the rising urgency for innovative solutions that meet the needs of public health initiatives.
Restraints in the Vaccine Delivery Devices Market
The Vaccine Delivery Devices market faces significant constraints due to the high costs associated with developing and manufacturing advanced technologies. The extensive research and development required can lead to substantial expenses, which are often transferred to end-users such as healthcare facilities and patients. This financial burden can hinder the widespread adoption of these innovative devices, especially in resource-limited environments. Consequently, the cost-related barriers may restrict access in certain regions, preventing the full realization of the benefits that these advanced vaccine delivery solutions can offer in enhancing immunization efforts and overall public health outcomes.
Market Trends of the Vaccine Delivery Devices Market
The Vaccine Delivery Devices market is witnessing a notable trend towards innovations in needle-free delivery systems, which are rapidly gaining traction among healthcare providers and patients alike. These advanced technologies, including jet injectors, microneedle patches, and nasal sprays, address common concerns associated with traditional needle-based vaccinations, such as anxiety and needle-stick injuries. By offering alternative delivery methods, these innovations not only enhance patient compliance but also improve vaccine stability and efficacy. As vaccination campaigns become increasingly critical, the shift towards needle-free solutions is expected to drive market growth, enhance operational efficiencies, and transform the overall vaccination experience.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Regulatory Landscape
- Patent Analysis
- Technology Analysis
Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2025-2032)
- Market Overview
- Needle-Free Injection Systems
- Oral Delivery Systems
- Nasal Delivery Systems
- Jet Injectors
- Microneedle Patches
- Microinjectors
Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2025-2032)
- Market Overview
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- Other Vaccinations
Global Vaccine Delivery Devices Market Size by End Users & CAGR (2025-2032)
- Market Overview
- Hospitals
- Clinics
- Other End Users
Global Vaccine Delivery Devices Market Size & CAGR (2025-2032)
- North America (Type of Device, Route of Administration, End Users)
- Europe (Type of Device, Route of Administration, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type of Device, Route of Administration, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type of Device, Route of Administration, End Users)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type of Device, Route of Administration, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Becton Dickinson & Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioject Medical Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inovio Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PharmaJet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vaxxas (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SCHOTT AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corium International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
